Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Boots Travel Calm Tablets

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Hyoscine hydrobromide may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Hyoscine hydrobromide
Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

How to take it

this medicine

PIL1863

Check the foil is not broken before use. If it is, do not take that tablet. Chew or swallow the first tablet (or part tablet) twenty minutes before your journey begins.

Information for the user

Travel Calm Tablets

Age

How many to take Adults and One tablet children of 12 years and over Children of Half a 7 to 11 tablet years

(Hyoscine Hydrobromide) This medicine is available without prescription • If you have heart failure, or a fast heart beat to treat minor conditions. However, you still • If you have kidney or liver problems need to take it carefully to get the best results • If you have an overactive thyroid from it.

  • If you have problems with your metabolism
  • Keep this leaflet, you may need to read it
  • If you are elderly again
  • If you are breastfeeding
  • Ask your pharmacist if you need more Other important information information or advice Driving and using machines: This medicine What this medicine is for may cause drowsiness. If affected do not drive This medicine contains Hyoscine or operate machinery. Hydrobromide which belongs to a group of Do not drink alcohol (e.g. wine, beer, spirits) medicines called anticholinergics. whilst taking this medicine. It can be used to prevent and relieve the Information about some of the ingredients: unpleasant effects of travel sickness. This medicine contains dextrose monohydrate, also known as glucose. If you have been told Before you take this medicine by your doctor that you have an intolerance to some sugars, contact your doctor before This medicine can be taken by adults and taking this medicinal product. children aged 3 years and over. However, some people should not take this medicine or should seek the advice of their pharmacist or If you take other medicines Before you take these tablets, make sure that doctor first. you tell your pharmacist about ANY other Do not take: medicines you might be using at the same
  • If you are allergic to any of the ingredients time, particularly the following:
  • If you have glaucoma
  • Other anticholinergic medicines (e.g.
  • If you have stomach problems or a amantidine for Parkinson's disease) blockage in your intestine
  • Antihistamines (for treating allergy or hayfever)
  • If you are a man with prostate problems • Butyrophenones, phenothiazines (for
  • If you have an intolerance to some mental problems) sugars, unless your doctor tells you to (this • Tricyclic antidepressants medicine contains glucose) If you are unsure about interactions with any
  • If you are pregnant, unless your doctor tells other medicines, talk to your pharmacist. This you to includes medicines prescribed by your doctor and medicine you have bought for yourself, Talk to your pharmacist or including herbal and homeopathic remedies.

doctor:

200 mm

200 mm

Read all of this leaflet carefully because it contains important information for you.

Children of Quarter of a tablet 3 to 6 years

How often to take it Every 6 to 8 hours, if you need to. Don't take more than 3 tablets in 24 hours. Every 6 to 8 hours, if you need to. Don't give more than 3 half tablets in 24 hours. Every 6 to 8 hours, if you need to. Don't give more than 3 quarter tablets in 24 hours.

Do not give to children under 3 years. Do not take more than the amount recommended above. If you take too many tablets: Talk to your doctor or go to your nearest hospital casualty department. Take the medicine and this leaflet with you.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or by searching for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

Possible side effects

Leaflet prepared June 2024 Most people will not have problems, but some If you would like any further information about may get some of these: this medicine, please contact

  • Drowsiness, giddiness, staggering The Boots Company PLC Nottingham
  • Dry mouth or nose, thirst, dry skin, difficulty in NG2 3AA. passing urine Other formats
  • Increased pressure in the eye, dislike of bright To request a copy of this leaflet in Braille, light, widening of the pupils in the eye, large print or audio please call, free of charge: changes in the muscles in the eye 0800 198 5000 (UK only)
  • Changes in heart rate, fast, irregular heart Please be ready to give the following beat information:
  • Constipation, being sick Product name: Boots Travel Calm Tablets
  • Increased number of fits if you have epilepsy Reference number: 00014/5369
  • Occasionally, hallucinations and confusion, This is a service provided by the particularly in children Royal National Institute of Blind People. PIL1863

How to store it

this medicine

Keep this medicine in a safe place out of the sight and reach of children, preferably in a locked cupboard. Use by the date on the end flap of the carton. Do not store above 30°C.

What is in this medicine

Each tablet contains Hyoscine Hydrobromide 0.3 mg, which is the active ingredient. As well as the active ingredient, the tablets also contain glucose, stearic acid, magnesium stearate. The pack contains 12 round white tablets. The tablets are scored on one side into a cross shape so that it can be broken into quarters.

Who makes this medicine

Manufactured for the Marketing Authorisation holder The Boots Company PLC Nottingham NG2 3AA by Bristol Laboratories Ltd Northbridge Road Berkhamsted Herts HP4 1EG

Frequently asked questions about Boots Travel Calm Tablets

How do I take Boots Travel Calm Tablets?

Boots Travel Calm Tablets comes as tablet. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Boots Travel Calm Tablets?

The active substance in Boots Travel Calm Tablets is hyoscine hydrobromide.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Boots Travel Calm Tablets, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Boots Travel Calm Tablets without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Hyoscine hydrobromide (5 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

For the prevention and relief of travel sickness.

4.2. Posology and method of administration

Adults and children over 12 years: One tablet.

Children 7 to 12 years: Half a tablet.

Children 3 to 7 years: Quarter of a tablet.

Not to be taken by children under 3 years.

Elderly: The normal adult dose is still appropriate in the elderly.

The dose should be taken 20 minutes before the journey and may be repeated in 6-8 hours if necessary.

Not more than three doses to be taken in 24 hours.

For oral administration.

4.3. Contraindications

Prostatic enlargement, paralytic ileus, pyloric stenosis, closed angle glaucoma.

4.4. Special warnings and precautions for use

Should be used with caution in conditions characterised by tachycardia such as thyrotoxicosis and cardiac failure. Should be used with caution by elderly patients and in patients suffering from impaired renal, hepatic or metabolic function.

Warning: May cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink.

There have been rare reports of an increase in frequency of seizures in epileptic patients.

Not more than three doses to be taken in 24 hours.

Keep all medicines out of the reach of children.

This medicine contains dextrose monohydrate, also known as glucose. Patients with rare glucose-galactose malabsorption should not take this medicine.

4.5. Interaction with other medicinal products and other forms of interaction

The effects of hyoscine may be enhanced by other drugs with anticholinergic properties, including amantadine, some antihistamines, butyrophenones, phenothiazines and tricyclic antidepressants. Patients should also avoid alcohol. The reduction in gastric motility caused by hyoscine may also affect the absorption of other drugs.

4.6. Pregnancy and lactation

The safety of hyoscine during pregnancy and lactation has not been established, although there is no definite evidence of adverse consequences if taken during early pregnancy. No significant quantities of hyoscine were found in milk when the drug was given to lactating women. Nevertheless, the product should not be used during pregnancy, unless the expected benefit is thought to outweigh any possible risk to the foetus.

4.7. Effects on ability to drive and use machines

Hyoscine may cause drowsiness and dulling of mental alertness and therefore those taking this medication should not take charge of motor vehicles or operate machinery.

4.8. Undesirable effects

Side effects may include drowsiness, dryness of the mouth, thirst, reduced bronchial secretions, mydriasis, loss of accommodation, photophobia, increased intra-ocular pressure, flushing, dry skin, bradycardia followed by tachycardia, with palpitations and arrhythmias, difficulty in micturition, reduction in tone and motility of the gastrointestinal tract leading to constipation. Occasionally vomiting, giddiness and staggering may occur. There have also been occasional reports of confused states and hallucinations when given to children.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or by searching for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Symptoms of overdosage may include any of the undesirable effects mentioned above under section 4.8 and tachycardia, rapid or stertorous respiration, hyperpyrexia, restlessness, confusion and excitement, hallucinations and delirium. In severe cases, depression of the central nervous system may occur with coma, circulatory and respiratory failure and death.

Treatment consists of emptying the stomach by lavage and aspiration. Charcoal may be used to prevent further absorption. Give a saline purgative, such as sodium sulphate 30g in 250ml of water.

Peripheral anticholinergic effects may be controlled by the administration of the antichlolinesterase, neostigmine. Excitement may be controlled by diazepam. Otherwise treatment should be symptomatic and supportive.

🇵🇱 Known in Poland as

Medicines sold in Poland with the same active substance: W Polsce znany jako

⚠ Not the same combination. This medicine contains Hyoscine hydrobromide. The products below do not contain exactly the same set of active substances — they are not direct substitutes.

  • Buscopan partial — not the same combinationHyoscini butylbromidum · taken by mouth
  • Buscopan forte partial — not the same combinationHyoscini butylbromidum · taken by mouth
  • AuroGastro partial — not the same combinationHyoscini butylbromidum · taken by mouth
  • Panadol Femina partial — not the same combinationParacetamolum + Hyoscini butylbromidum · taken by mouth
  • Scopolan compositum partial — not the same combinationHyoscini butylbromidum + Metamizolum natricum monohydricum · taken by mouth

Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →

💬 Ask about this leaflet

Ask anything about Boots Travel Calm Tablets. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →